K Number
K202110
Date Cleared
2021-11-05

(463 days)

Product Code
Regulation Number
882.5810
Panel
NE
Reference & Predicate Devices
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The MStim Drop LGT-233 is intended to provide ankle dorsiflexion in individuals who have a dropped foot as a consequence of upper motor neuron injury. The device electrically stimulates muscles in the affected leg to provide ankle dorsiflexion of the foot and/or knee flexion or extension; thus, it also may improve the individual's gait. The MStim Drop LGT-233 may also:

·Prevent/retard disuse atrophy

· Maintain or increase joint range of motion

•Increase local blood flow

Device Description

The MStim Drop LGT 233 is a wearable foot drop device, which is mainly consist s of stimulator main unit, electrode lead wire, electrodes pad, leg bandage and battery charger. The stimulator main unit can be charge by the battery charger.

The device can control the out stimulation and treatment time setting by APP application provided by the manufacturer, and it can trigger and control the pulse stimulation on and off by detecting the swing phase of gait during walking. The device was design to use FES (Functional Electrical Stimulation) to treat and improve the patient s foot drop and help to improve walking ability. It has two modes: Training mode, Walk mode. Training mode is suitable for muscle training when the patient is seated or lying down (patient lacking active training), which can promote muscle recover, prevent muscle atrophy, improve joint range of motion, and increase local blood flow. Walk mode is walking with the electrical stimulation.

AI/ML Overview

The MStim Drop Model: LGT-233 is an external functional neuromuscular stimulator intended to provide ankle dorsiflexion in individuals with dropped foot due to upper motor neuron injury. It electrically stimulates muscles to improve gait and may also prevent/retard disuse atrophy, maintain or increase joint range of motion, and increase local blood flow.

Here's an analysis of the provided information regarding acceptance criteria and studies:

1. Table of Acceptance Criteria and Reported Device Performance

The provided document (a 510(k) summary) does not explicitly state "acceptance criteria" in a quantitative, measurable sense for clinical performance. Instead, it demonstrates substantial equivalence to predicate devices through a comparison of technical specifications and an assertion of compliance with various electrical safety and biocompatibility standards. The reported device performance is largely a direct comparison of its technical specifications to those of the predicate devices.

Here's a table summarizing the comparison of key technical elements. "SE" in the remark column indicates "Substantially Equivalent” as claimed by the manufacturer. "Minor difference" remarks are explained in the "Comparison in Detail(s)" section of the document.

Elements of ComparisonSubject Device (MStim Drop Model: LGT-233)Predicate Device I (L300 Go System, K162407)Predicate Device II (MyGait Stimulation System, K141812)Remark
Indications for UseProvides ankle dorsiflexion, improves gait, prevents atrophy, maintains/increases ROM, increases local blood flow.Provides ankle dorsiflexion, assists knee flexion/extension, improves gait.Provides ankle dorsiflexion and knee flexion/extension, improves gait, prevents/retards atrophy, facilitates muscle reeducation, maintains/improves ROM, promotes local blood circulation.SE
Apply partsLegLeg and footLeg and footSE
Power SourcesAdapter supply: AC 100~240V, Battery: 3.7V, 1200mAh, lithium.Battery operatedBattery operatedMinor difference (Note 1)
Indicator displayLED and APP----Minor difference (Note 1)
Method of Line Current IsolationBattery operated--Medical Class II Power AdapterSE
Number of Modes for Micro current stimulation2 (Training mode, Walk mode)Two modes: Biphasic Symmetric and Biphasic Asymmetric.2SE
Number of Channels for Micro current stimulation11-2 channels depending on cuff.2SE
Synchronous or AlternatingNot applicable – single channel deviceAlternatingSynchronous or alternatingSE
Regulated Current or Regulated VoltageRegulated VoltageCurrentRegulated CurrentSE (Note 2 refers to Timer Range, not this)
Software/Firmware/Microprocessor controlYesYesYesSE
Automatic Overload TripYesYesYesSE
Automatic No-load TripYesYesYesSE
Automatic Shut OffYesYesNoSE
Patient Override ControlYesYesYes (ON/OFF Button)SE
Indicator Display (Status, Low Battery, Voltage/Current Level)Yes (On/Off Status, Low Battery); No (Voltage/Current Level)Yes for allYes for allSE (Remark for each, although Voltage/Current is 'No' for subject device)
Timer Range1min-60min, stepping 1minMax stimulation duration (clinician selectable) Training mode: 5-60 minutes5 to 120min in steps of 5 minMinor difference (Note 2)
Console weight60g (main unit)Control Unit: 60g, EPG: 60g, Lower leg FSC:150g, Thigh cuff: 300g, Foot Sensor: 25g78gSE
Housing Materials and ConstructionABSMixed (Polycarbonate + ABS, Biocompatible fabric, POM Hi, TPU)ABSSE
WaveformBiphasic squareBiphasic SymmetricalBiphasicSE
ShapeRectangularRectangularRectangularSE
Maximum Output Voltage (+/- 10%)50V @ 500Ω, 90V @ 1KΩ, 120V @ 2KΩ, 130V @ 10KΩLower leg: 50V@500Ω, 130V@2KΩ, 130V@10KΩ; Thigh: 50V@500Ω, 130V@2KΩ, 130V@10KΩ45V @ 500Ω, 90V @ 1KΩ, 120V@2KΩ, n/a @10KΩMinor difference (Note 3)
Maximum output Current100mA @ 500Ω, 90mA @ 1KΩ, 60mA @ 2KΩ, 13mA @ 10KΩLower leg: 100mA@500Ω, 65mA@2KΩ, 13mA@10KΩ; Thigh: 100mA@500Ω, 65mA@2KΩ, 13mA@10KΩ90mA @ 500Ω, 90mA @ 1KΩ, 60mA@2KΩ, n/a @10KΩMinor difference (Note 3)
Frequency range10~80Hz10, 15, 20, 25, 30, 35, 40, 45 Hz10 to 80Hz in 1Hz stepsMinor difference (Note 4)
Pulse width range50~500µs100, 150, 200, 250, 300µs (each: positive and phase)Symmetrical: 50 400µs in steps of 50µs; Asymmetrical: pos.: 50 ~ 400µs, Neg.: 2001600µsMinor difference (Note 4)
Pulse duration50~500µsPositive phase: 100, 150, 200, 250, 300 µs; Negative phase: 100, 150, 200, 250, 300 µsSymmetrical: 50 400µs in steps of 50µs; Asymmetrical: pos.: 50 ~ 400µs, Neg.: 2001600µsMinor difference (Note 4)
Net Charge0uC @ 500Ω0µC using inverted balanced phases0µC @ 500Ω Balanced pulsesSE
Maximum Current DensityTrain mode: 0.532mA/cm²@500Ω, Walk mode: 0.53mA/cm²@500ΩLower leg (small cuff): 1.63 mA/cm² (rms), Lower leg (regular cuff): 1.04 mA/cm² (rms), Thigh: 0.23 mA/cm² (rms)1.51 mA/cm² @500ΩMinor difference (Note 5)
Maximum Power DensityTrain mode: 5.66 mW/cm²@500Ω, Walk mode: 5.62 mW/cm²@500ΩLower leg (small cuff): 13.4 mW/cm², Lower leg (regular cuff): 8.5 mW/cm², Thigh: 1.9 mW/cm²0.024 W/cm²Minor difference (Note 5)
ON timeFor Train mode: 2~40s, For Walk mode: N/ATraining mode: 4-20 sec, Gait mode: 1-10 sec1 to 4 sec in 0.1sec stepsMinor difference (Note 6)
OFF timeFor Train mode: 2.0~60.0s, For Walk mode: N/A (swing phase detecting)Training mode: 4-20 sec, Gait mode: not limited (swing phase detecting)1 to 30 sec in 1sec stepsMinor difference (Note 6)
Contraction and Relaxation timeAdjustable--AdjustableSE
Environment for operatingTemperature: 5 to 40°C; Rel. humidity: ≤80%--No specific values listed in comparison table.SE
Environment for storage and transportTemperature: -20 to 55°C; Rel. humidity: ≤93%--No specific values listed in comparison table.SE
BiocompatibilityCompliant with ISO10993-5, -10, -12No specific standards listed in comparison table.No specific standards listed in comparison table.SE
Electrical Safety, EMCCompliant with IEC 60601-1, -2-10, -1-2, -1-11, IEC 62133-2IEC 60601-1, IEC 60601-1-2, IEC 60601-2-10, FCC part 15 subpart C and B1IEC 60601-1:2005+A1:2012; IEC 60601-1-11:2010; IEC 60601-2-10:2012; IEC 60601-1-2:2007SE

2. Sample size used for the test set and the data provenance (e.g., country of origin of the data, retrospective or prospective)

The document primarily relies on bench testing for safety and performance evaluation against recognized standards (IEC, ANSI, ISO). There is no mention of a human clinical study or "test set" in the context of clinical performance data used for this 510(k) submission. Therefore, sample size and data provenance for a clinical test set are not applicable here.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g., radiologist with 10 years of experience)

Not applicable, as no clinical test set for performance involving ground truth established by experts is described for this submission. The submission focuses on substantial equivalence based on technical specifications and compliance with safety standards.

4. Adjudication method (e.g., 2+1, 3+1, none) for the test set

Not applicable, as no clinical test set requiring adjudication is described.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

Not applicable. This device is an electrical stimulator, not an AI-powered diagnostic tool requiring reader performance evaluation.

6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done

Not applicable. This is not an algorithm-only device.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)

For the safety and performance evaluation reported, the "ground truth" used is compliance with various international standards for medical electrical equipment (e.g., IEC 60601 series), battery safety (IEC 62133-2), and biological evaluation (ISO 10993 series). These standards define acceptable limits and testing methodologies for device characteristics. No clinical outcomes data or expert consensus on clinical effectiveness is presented as "ground truth" in this submission.

8. The sample size for the training set

Not applicable. This device does not appear to incorporate machine learning algorithms that require a "training set" in the context of AI model development.

9. How the ground truth for the training set was established

Not applicable, as no training set for AI model development is mentioned.

§ 882.5810 External functional neuromuscular stimulator.

(a)
Identification. An external functional neuromuscular stimulator is an electrical stimulator that uses external electrodes for stimulating muscles in the leg and ankle of partially paralyzed patients (e.g., after stroke) to provide flexion of the foot and thus improve the patient's gait.(b)
Classification. Class II (performance standards).